TL;DR
This study investigates a Chinese family with hypertrophic cardiomyopathy (HCM) exhibiting a rare combination of early repolarization (ER) and short QT syndrome (SQTS). The researchers identified novel trigenic mutations in CACNA1C, DES, and MYPN genes, suggesting these mutations are key to the complex clinical presentation. This work highlights the intricate genetic underpinnings of HCM and the potential for multiple genetic defects to synergistically influence disease severity.
What Problem Does This Paper Address?
Hypertrophic cardiomyopathy (HCM) is a significant cause of sudden cardiac death, characterized by unexplained cardiac hypertrophy. While genetic factors are well-established, the specific genetic basis for HCM patients presenting with early repolarization (ER) patterns and short QT syndrome (SQTS) remains poorly understood. ER is typically associated with an increased risk of ventricular arrhythmias, and its co-occurrence with SQTS in HCM patients presents a complex clinical challenge. This paper aims to unravel the genetic architecture underlying this specific, rare phenotype within an affected family.
Methods
The researchers employed a multi-pronged approach:
- Clinical Assessment: Detailed medical evaluations, including ECGs, echocardiograms (UCG), and blood tests, were performed on family members.
- Genetic Screening: DNA was extracted from peripheral blood leukocytes. Targeted exome sequencing of 120 genes implicated in cardiovascular diseases was used to identify novel mutations.
- Mutation Validation: Identified mutations were validated through conventional Sanger sequencing.
- Bioinformatic Analysis: In silico tools like MutationTaster2, Polyphen2, and PROVEAN were used to predict the pathogenicity of the identified variants. Protein structure modeling (SWISS-MODEL) was employed to visualize the impact of mutations on protein structure.
- Functional Characterization: For the CACNA1C mutation, heterologous expression in TSA201 cells was performed. Whole-cell patch-clamp experiments were conducted to measure calcium currents (ICa) and assess their voltage-dependent activation and steady-state inactivation.
Datasets
Not explicitly detailed as separate datasets. The study utilized DNA samples from a single Chinese family.
Key Insights and Ideas
- Trigenic Mutations as Pathogenic Substrates: The study strongly suggests that the combination of mutations in CACNA1C, DES, and MYPN acts synergistically to drive the complex clinical manifestations observed in this HCM family.
- CACNA1C Mutation and ER/SQTS Link: The novel CACNA1C mutation (p.R1973P) appears to be a primary driver of the ER pattern and short QT intervals, likely through a loss-of-function mechanism affecting calcium channel activity.
- DES and MYPN Mutations Contribute to HCM Phenotype: Mutations in DES and MYPN, known to be involved in cytoskeletal integrity and sarcomere function, likely contribute to the hypertrophic cardiomyopathy phenotype and potentially to conduction abnormalities.
- Complex Genetic Interactions: The findings underscore that HCM is not always caused by a single gene defect, and multiple genetic hits can lead to a more severe and atypical presentation.
- CRT-D Effectiveness in HCM: The study provides clinical support for the effectiveness of cardiac resynchronization therapy with defibrillator (CRT-D) in reducing left ventricular outflow tract (LVOT) gradients in patients with obstructive HCM, even in cases refractory to other treatments.
Key Results
- Identification of Novel Mutations: Three novel missense mutations were identified in the proband: c.700G>A/p.E234K in DES, c.2966G>A/p.R989H in MYPN, and c.5918G>C/p.R1973P in CACNA1C.
- Family Segregation: The daughter of the proband carried all three mutations, while the elder sister carried none.
- CACNA1C Functional Impact: The CACNA1C-R1973P mutation caused a significant reduction (68.4%) in peak calcium current density compared to wild-type.
- Clinical Improvement with CRT-D: The proband experienced a dramatic reduction in LVOT gradient (from 124 mmHg to 27 mmHg) and improved LV function (LVEF from 40% to 63%) after CRT-D implantation.
- ER and SQTS Association: The CACNA1C mutation was linked to the ER pattern and short QT intervals, with the R1973P mutant showing a negative shift in the mid-inactivation potential, consistent with a loss-of-function phenotype.
Limitations and Future Work
- Incomplete Family History: The study acknowledges limitations due to an incomplete family history, making it difficult to definitively attribute the exact role of each mutation in the genesis of all clinical phenotypes.
- Limited Functional Data for DES/MYPN: While computational modeling was performed for DES and MYPN mutations, direct functional characterization of these specific mutations was not conducted.
- Future Directions: The authors plan to generate induced pluripotent stem cells (hiPSCs) from skin tissue of the proband and family members to replicate the disease phenotype at the cellular level and conduct further research. They also intend to continuously follow the daughter and her son to observe the progressive nature of the disease.
Summary updated